🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
02/03/1989 0,0652 USD
29/11/1988 0,0588 USD
29/08/1988 0,0469 USD
03/06/1988 0,0509 USD
29/02/1988 0,0509 USD
01/12/1987 0,0424 USD
28/08/1987 0,0424 USD
02/06/1987 0,0292 USD
02/03/1987 0,0292 USD
02/12/1986 0,0292 USD
02/09/1986 0,0292 USD
03/06/1986 0,0239 USD
27/02/1986 0,0239 USD
03/12/1985 0,0239 USD
30/08/1985 0,0212 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/04/1999 76,75 76,93 75,56 76,28 -0,23% 1,79% 4.224.278
31/03/1999 78,13 78,72 76,46 76,46 -2,58% 2,90% 3.981.247
30/03/1999 77,17 78,66 76,93 78,48 +0,61% 2,24% 3.058.169
29/03/1999 77,29 78,48 77,11 78,01 +1,71% 1,77% 3.767.560
26/03/1999 78,01 78,07 76,57 76,69 -2,65% 1,91% 4.296.066
25/03/1999 78,54 78,96 77,29 78,78 +0,23% 2,13% 4.269.447
24/03/1999 78,96 79,14 77,53 78,60 -0,75% 2,04% 3.911.136
23/03/1999 82,78 83,25 78,36 79,20 -3,91% 5,91% 4.808.224
22/03/1999 82,18 83,02 81,41 82,42 +0,44% 1,96% 2.732.555
19/03/1999 83,25 83,37 82,06 82,06 +0,00% 1,58% 6.392.276
18/03/1999 80,15 82,96 80,15 82,06 +2,38% 3,50% 3.997.910
17/03/1999 81,82 81,88 79,91 80,15 -2,18% 2,41% 4.016.565
16/03/1999 81,11 82,54 80,99 81,94 +1,93% 1,91% 5.421.304
15/03/1999 80,09 80,75 79,56 80,39 +0,45% 1,49% 4.642.954
12/03/1999 79,38 80,15 77,59 80,03 +1,28% 3,23% 8.644.952
11/03/1999 79,38 79,38 77,53 79,02 +0,00% 2,33% 4.679.425
10/03/1999 78,72 79,02 77,83 79,02 -0,38% 1,52% 5.138.763
09/03/1999 78,66 79,79 77,89 79,32 +0,23% 2,43% 4.574.939
08/03/1999 77,65 79,79 77,53 79,14 +0,23% 2,92% 6.287.686
05/03/1999 78,13 79,14 77,77 78,96 +2,87% 1,76% 6.492.360
04/03/1999 74,90 76,93 74,43 76,75 +2,55% 3,34% 5.516.462
03/03/1999 75,74 76,04 74,43 74,84 -1,26% 2,13% 3.681.414
02/03/1999 76,34 77,23 75,08 75,80 -0,39% 2,81% 3.852.343
01/03/1999 77,89 77,89 75,74 76,10 -2,15% 2,76% 3.690.951
26/02/1999 77,65 78,24 75,26 77,77 +0,85% 3,84% 4.470.139
25/02/1999 75,50 77,47 75,14 77,11 +1,65% 3,08% 4.484.392
24/02/1999 76,81 78,18 75,62 75,86 -1,93% 3,34% 3.715.474
23/02/1999 78,01 78,24 76,63 77,35 -0,84% 2,06% 5.021.911
22/02/1999 75,86 78,01 75,26 78,01 +3,48% 3,62% 7.193.367
19/02/1999 74,25 75,86 73,59 75,38 +1,44% 3,05% 4.694.306